Sequence requirements for the biotinylation of carboxyl-terminal fragments of human propionyl-CoA carboxylase alpha subunit expressed in Escherichia coli - PubMed (original) (raw)
. 1994 Sep 16;269(37):22964-8.
Affiliations
- PMID: 8083196
Free article
Sequence requirements for the biotinylation of carboxyl-terminal fragments of human propionyl-CoA carboxylase alpha subunit expressed in Escherichia coli
A Leon-Del-Rio et al. J Biol Chem. 1994.
Free article
Abstract
Biotin-dependent enzymes play an essential role in the metabolism of all organisms. Their biotinylation is catalyzed by holoenzyme synthetases, which attach a biotin molecule to a specific lysine residue on the apoenzymes. The sequence flanking the biotin binding site is highly conserved among biotin-dependent enzymes. This sequence conservation might be related to the extensive cross-species activity showed by holoenzyme synthetases. In this study, we have expressed carboxyl-terminal fragments of the alpha subunit of human propionyl-CoA carboxylase (PCC-alpha) in Escherichia coli and used site-directed mutagenesis to determine the sequence requirements for biotinylation by the bacterial holoenzyme synthetase. We show that the carboxyl-terminal 67 amino acids of PCC-alpha act as an independent domain in the biotinylation reaction. Mutations that affect several conserved Gly residues and a Pro-Met-Pro sequence near the biotin binding site are critical for biotinylation. Substitution of the amino acids that flank the biotin acceptor Lys residue or elimination of the last 3 amino acids of the PCC-alpha peptides had little or no effect on their biotinylation despite their high conservation in biotin enzymes.
Similar articles
- Sequence homology around the biotin-binding site of human propionyl-CoA carboxylase and pyruvate carboxylase.
Lamhonwah AM, Quan F, Gravel RA. Lamhonwah AM, et al. Arch Biochem Biophys. 1987 May 1;254(2):631-6. doi: 10.1016/0003-9861(87)90146-9. Arch Biochem Biophys. 1987. PMID: 3555348 - A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation.
Beckett D, Kovaleva E, Schatz PJ. Beckett D, et al. Protein Sci. 1999 Apr;8(4):921-9. doi: 10.1110/ps.8.4.921. Protein Sci. 1999. PMID: 10211839 Free PMC article. - The biotin enzyme family: conserved structural motifs and domain rearrangements.
Jitrapakdee S, Wallace JC. Jitrapakdee S, et al. Curr Protein Pept Sci. 2003 Jun;4(3):217-29. doi: 10.2174/1389203033487199. Curr Protein Pept Sci. 2003. PMID: 12769720 Review. - [Importance of biotin metabolism].
Rodríguez Meléndez R. Rodríguez Meléndez R. Rev Invest Clin. 2000 Mar-Apr;52(2):194-9. Rev Invest Clin. 2000. PMID: 10846444 Review. Spanish.
Cited by
- Human holocarboxylase synthetase with a start site at methionine-58 is the predominant nuclear variant of this protein and has catalytic activity.
Bao B, Wijeratne SS, Rodriguez-Melendez R, Zempleni J. Bao B, et al. Biochem Biophys Res Commun. 2011 Aug 19;412(1):115-20. doi: 10.1016/j.bbrc.2011.07.055. Epub 2011 Jul 23. Biochem Biophys Res Commun. 2011. PMID: 21802411 Free PMC article. - Management of a patient with holocarboxylase synthetase deficiency.
Van Hove JL, Josefsberg S, Freehauf C, Thomas JA, Thuy le P, Barshop BA, Woontner M, Mock DM, Chiang PW, Spector E, Meneses-Morales I, Cervantes-Roldán R, León-Del-Río A. Van Hove JL, et al. Mol Genet Metab. 2008 Dec;95(4):201-5. doi: 10.1016/j.ymgme.2008.09.006. Epub 2008 Oct 29. Mol Genet Metab. 2008. PMID: 18974016 Free PMC article. - Selectivity in post-translational biotin addition to five human carboxylases.
Ingaramo M, Beckett D. Ingaramo M, et al. J Biol Chem. 2012 Jan 13;287(3):1813-22. doi: 10.1074/jbc.M111.275982. Epub 2011 Nov 28. J Biol Chem. 2012. PMID: 22123817 Free PMC article. - Qualitative and quantitative analysis of the effect of splicing mutations in propionic acidemia underlying non-severe phenotypes.
Clavero S, Pérez B, Rincón A, Ugarte M, Desviat LR. Clavero S, et al. Hum Genet. 2004 Aug;115(3):239-47. doi: 10.1007/s00439-004-1147-1. Epub 2004 Jul 2. Hum Genet. 2004. PMID: 15235904 - The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency.
Baumgartner MR, Almashanu S, Suormala T, Obie C, Cole RN, Packman S, Baumgartner ER, Valle D. Baumgartner MR, et al. J Clin Invest. 2001 Feb;107(4):495-504. doi: 10.1172/JCI11948. J Clin Invest. 2001. PMID: 11181649 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous